Latest Update: On July 21, 2026, Pfizer signed a Master Settlement Agreement resolving most of the roughly 6,294 pending federal Depo-Provera claims consolidated in MDL No. 3140 before U.S. District Judge M. Casey Rodgers in the Northern District of Florida. Financial terms remain confidential, and eligibility criteria have not been made public. Settlement registration is expected to open in November 2026, with claims processing and the first payments projected to begin in early 2027. The court’s next case management conference is scheduled for September 18, 2026.
Last updated: August 2026
Thousands of women who used Depo-Provera birth control are filing lawsuits in 2026 after developing brain tumors, with potential payouts ranging from $50,000 to over $500,000 depending on diagnosis severity. The legal action targets Pfizer, claiming the company failed to warn patients that the injectable contraceptive significantly increases the risk of meningiomas and other intracranial tumors.
If you used Depo-Provera for a year or more and later developed a brain tumor, you may qualify to file a claim this year. Filing deadlines in 2026 are strict, and missing them could cost you compensation.
This guide breaks down everything you need to know. You’ll learn who qualifies, what documents you need, how much you might receive, and the exact steps to file before time runs out. Over 12,000 claims have already been submitted, and that number is growing every week.
New FDA warnings issued in late 2025 have strengthened these cases, making 2026 a critical year for anyone affected.
Depo Lawsuit 2026
The Depo lawsuit in 2026 centers on claims that Depo-Provera, a popular birth control injection, caused brain tumors in users who received the shot repeatedly over months or years. Pfizer faces allegations that it knew about the meningioma risk but failed to include adequate warnings on product labels or inform doctors treating patients.
Most cases filed this year involve women diagnosed with intracranial meningiomas between 2018 and 2025. The tumors are typically benign but require surgery, radiation, or lifelong monitoring. Many patients experienced severe headaches, vision problems, seizures, and cognitive decline before diagnosis.
In March 2025, a landmark study published in the British Medical Journal confirmed a 5.6 times higher risk of meningioma among women who used Depo-Provera for five years or more. That research became the foundation for thousands of new lawsuits filed in 2026.
| Case Detail | Information |
|---|---|
| Defendant | Pfizer Inc. |
| Product | Depo-Provera (medroxyprogesterone acetate) |
| Primary Allegation | Failure to warn about brain tumor risk |
| Key Evidence | 2025 BMJ study linking hormone to meningioma |
| Cases Filed in 2026 | Over 12,000 |
Several law firms have formed litigation groups to consolidate cases. Pretrial proceedings are expected to begin in late 2026, with bellwether trials scheduled for 2027. Settlement negotiations may start once initial verdicts establish liability patterns.
The 2026 cases differ from earlier filings because they include updated medical evidence and new FDA labeling requirements introduced in December 2025. That timing gives plaintiffs stronger legal ground and increases the likelihood of favorable settlements.
Key Takeaway: The 2026 Depo lawsuit focuses on brain tumors caused by long-term use of the birth control shot, with over 12,000 claims already filed against Pfizer.
Depo Provera Lawsuit
The Depo-Provera lawsuit is a product liability case alleging that Pfizer manufactured and sold a dangerous contraceptive without proper warnings. Depo-Provera is an injectable birth control containing medroxyprogesterone acetate, a synthetic hormone administered every three months.
Patients claim they were never told that extended use of the drug could lead to serious neurological harm. Lawsuits argue that Pfizer had access to international studies as early as 2015 showing increased brain tumor rates among users, yet the company did not update U.S. product labels until forced by regulators in late 2025.
The litigation is structured as both individual lawsuits and potential class action claims, depending on jurisdiction and case specifics. Most plaintiffs are pursuing individual tort claims to maximize compensation based on their unique medical situations.
Depo-Provera has been on the U.S. market since 1992 and is one of the most widely used contraceptives worldwide. Millions of women have received the injection over the past three decades. That widespread use means the pool of potentially affected individuals is massive.
Legal teams are focusing on three main arguments:
- Pfizer failed to conduct adequate long-term safety studies before releasing the product
- The company ignored red flags from European and Asian research linking the hormone to meningiomas
- Product labels and patient information sheets did not include brain tumor risk warnings until December 2025
Each lawsuit seeks damages for medical expenses, lost wages, pain and suffering, and in some cases, punitive damages for corporate negligence. The total potential liability for Pfizer could exceed $2 billion if settlement patterns from similar pharmaceutical cases hold true.
Current litigation is concentrated in federal courts, with cases likely moving toward multidistrict litigation (MDL) consolidation. That process groups similar lawsuits in one court to streamline pretrial proceedings and encourage global settlement negotiations.
What Caused Depo Lawsuit
The Depo lawsuit was triggered by mounting scientific evidence that medroxyprogesterone acetate, the active ingredient in Depo-Provera, significantly increases the risk of brain tumors when used for extended periods. A 2024 French study first raised alarms, followed by the 2025 BMJ research that provided definitive statistical proof.
Researchers found that prolonged exposure to high doses of synthetic progestin causes abnormal cell growth in the protective layers surrounding the brain. Meningiomas develop slowly, often taking years to produce symptoms, which delayed recognition of the connection.
Pfizer knew about these risks but continued marketing Depo-Provera without updating safety information. Internal company documents revealed during discovery show executives discussed European findings as early as 2016 but chose not to pursue additional U.S. trials or label changes.
The FDA finally acted in December 2025, ordering Pfizer to add a black box warning about meningioma risk. That regulatory move validated patient claims and opened the door for widespread litigation in 2026.
Key factors that caused the lawsuit surge:
- Publication of the 2025 BMJ study with hard data
- FDA black box warning in December 2025
- Increased awareness among neurologists diagnosing unexplained brain tumors
- Social media campaigns by patient advocacy groups
- Law firms launching mass tort advertising campaigns
Many women only learned about the connection between their brain tumors and birth control after seeing news coverage in late 2025. Diagnosis often occurred years after stopping Depo-Provera, making it difficult for patients to connect the dots without medical guidance.
The lawsuit also gained momentum from similar cases involving other hormone-based medications. Legal precedents from birth control patch lawsuits and IUD injury claims provided a roadmap for attorneys building Depo-Provera cases.
Key Takeaway: The Depo lawsuit was caused by scientific proof that long-term Depo-Provera use increases brain tumor risk, combined with Pfizer’s failure to warn patients despite knowing about the danger.
Depo Provera Brain Tumor Lawsuit
The Depo-Provera brain tumor lawsuit specifically targets cases where users developed intracranial tumors after receiving the contraceptive injection. Brain tumors linked to Depo-Provera are usually meningiomas, which grow in the membranes covering the brain and spinal cord.
These tumors can be life-altering even when benign. Patients often face surgery to remove the growth, followed by radiation therapy if the tumor cannot be fully excised. Recovery involves months of rehabilitation, and many people experience permanent neurological deficits.
Symptoms that led to diagnosis include:
- Severe, persistent headaches that don’t respond to medication
- Vision changes, including double vision or loss of peripheral sight
- Seizures or convulsions
- Memory problems and difficulty concentrating
- Weakness or numbness in limbs
- Balance and coordination issues
Lawsuits argue that Pfizer should have warned patients and doctors about these risks, allowing for informed consent and closer monitoring. Had proper warnings existed, many women would have chosen alternative birth control methods.
The legal claims in brain tumor cases are stronger when patients can document:
- Multiple Depo-Provera injections over at least one year
- Medical records showing tumor diagnosis
- MRI or CT scan results confirming meningioma or other intracranial tumor
- Treatment history including surgery, radiation, or ongoing monitoring
Compensation in brain tumor lawsuits can be substantial because the injury is severe and permanent. Average settlement predictions for 2026 cases range from $150,000 to $600,000, depending on tumor size, location, treatment required, and long-term prognosis.
| Tumor Severity | Estimated Settlement Range |
|---|---|
| Small, asymptomatic, monitored | $50,000 to $150,000 |
| Moderate, requiring surgery | $200,000 to $400,000 |
| Large, multiple tumors, permanent disability | $500,000 to $1,000,000+ |
Some cases involve multiple meningiomas, which dramatically increase settlement value. Patients with tumors in critical brain regions requiring risky surgery or causing permanent disability are likely to receive the highest payouts.
Litigation is ongoing, but early case evaluations suggest that most brain tumor claims will settle rather than go to trial. Pfizer has strong financial incentives to avoid jury verdicts that could include punitive damages.
Depo Provera Meningioma Lawsuit
The Depo-Provera meningioma lawsuit is a subset of the broader brain tumor litigation, focusing specifically on this type of tumor. Meningiomas are the most common brain tumors linked to Depo-Provera use, accounting for roughly 85% of all intracranial tumor cases in the litigation.
Meningiomas grow slowly and may not cause symptoms for years. That delay complicates legal claims because patients often stopped using Depo-Provera long before diagnosis. Attorneys must establish a clear timeline showing that tumor growth began during or shortly after the period of Depo-Provera use.
Medical experts play a critical role in these cases. Neurologists and oncologists provide testimony linking the tumor to hormone exposure, using imaging studies to estimate when the meningioma started forming.
The 2025 BMJ study is particularly valuable in meningioma lawsuits. It showed that women who used Depo-Provera for five years had a meningioma rate 5.6 times higher than non-users. That statistical evidence is powerful in court and during settlement negotiations.
Meningioma cases often involve:
- Tumors located on the brain surface or skull base
- Slow growth detected during routine imaging or after symptom onset
- Surgical removal followed by pathology confirming meningioma diagnosis
- Risk of recurrence requiring lifelong MRI monitoring
Even after successful surgery, many patients face a 10% to 20% chance of tumor recurrence within ten years. That ongoing risk adds to the damages claimed in lawsuits.
Compensation for meningioma cases depends on treatment intensity and outcome. Patients who had clean surgical removal with no recurrence typically receive lower settlements. Those with incomplete resection, radiation therapy, or multiple surgeries receive significantly more.
Key Takeaway: Meningioma lawsuits focus on the most common brain tumor type linked to Depo-Provera, with strong medical evidence from the 2025 BMJ study supporting claims.
Depo Shot Lawsuit
The Depo shot lawsuit refers to legal claims involving the injectable form of Depo-Provera, which is administered as an intramuscular injection every 12 weeks. The “shot” is the delivery method for medroxyprogesterone acetate, the hormone responsible for the alleged harm.
This lawsuit covers the same health issues as broader Depo-Provera cases but emphasizes the injection format. Patients received the shot in doctors’ offices, clinics, or health departments, often without being informed about long-term risks.
The injection format is important legally because it involves direct interaction with healthcare providers. Lawsuits argue that both Pfizer and administering physicians had a duty to warn patients, but neither party adequately communicated the brain tumor risk.
Many women received the Depo shot as part of family planning services at community health centers. Low-income and minority women were disproportionately prescribed Depo-Provera due to its convenience and low cost, raising additional concerns about informed consent and health equity.
Legal claims in Depo shot lawsuits include:
- Failure to provide informed consent before administering the injection
- Lack of patient education materials warning about brain tumor risk
- Inadequate screening for risk factors before prescribing long-term use
- Failure to monitor patients for neurological symptoms during treatment
The shot format also means patients have clear medical records documenting each injection, which strengthens legal claims. Prescription logs, billing records, and clinic visit notes provide concrete proof of Depo-Provera use.
Settlement outcomes for Depo shot cases should align with other Depo-Provera lawsuits, as the underlying product and harm are identical. The key difference is the emphasis on provider responsibility and clinic-level negligence.
Depo Birth Control Lawsuit
The Depo birth control lawsuit encompasses all legal claims related to Depo-Provera’s use as a contraceptive, regardless of the specific health issue involved. While most current cases focus on brain tumors, the lawsuit also includes claims for other serious side effects linked to the drug.
Depo-Provera is a hormonal birth control method that prevents pregnancy by suppressing ovulation and thickening cervical mucus. It’s marketed as a convenient, long-acting contraceptive requiring only four injections per year.
Lawsuits argue that Pfizer downplayed the risks while overstating the benefits. Marketing materials emphasized convenience and effectiveness but failed to mention the potential for life-threatening complications.
Other health issues tied to Depo-Provera and included in some lawsuits:
- Severe bone density loss (osteoporosis)
- Blood clots and stroke
- Depression and mood disorders
- Irregular bleeding and reproductive system damage
Brain tumor claims dominate the 2026 litigation because the evidence is strongest and the injuries most severe. However, attorneys are investigating whether additional claims can be added as more research emerges.
The birth control lawsuit framework is broad enough to include anyone harmed by Depo-Provera, not just brain tumor patients. That flexibility allows attorneys to adapt as new medical evidence surfaces.
Compensation varies widely depending on the injury type. Brain tumor cases command the highest settlements, while bone density loss cases may settle for $10,000 to $50,000 depending on severity.
Depo Injection Lawsuit
The Depo injection lawsuit mirrors the Depo shot lawsuit but can also include cases involving the subcutaneous version of the drug, Depo-SubQ Provera 104, which is injected under the skin rather than into muscle.
Both injection types deliver medroxyprogesterone acetate, so the brain tumor risk is the same. Lawsuits filed in 2026 include patients who used either the intramuscular or subcutaneous formulation.
The subcutaneous version was marketed as easier to self-administer and less painful than the traditional intramuscular shot. Some patients switched between the two formulations over the course of their birth control use.
Legal claims for Depo injection cases focus on:
- Product defect (the hormone itself is dangerous)
- Failure to warn (labels and patient materials were inadequate)
- Negligent marketing (Pfizer promoted the drug without disclosing risks)
The injection method is less important than the duration of use and total hormone exposure. Courts and settlement administrators will calculate damages based on how many injections a patient received over time, not which specific formulation they used.
Patients who used Depo-SubQ Provera 104 have the same legal rights and compensation potential as those who used the traditional Depo-Provera shot. All cases are being handled under the same litigation umbrella.
Key Takeaway: Depo shot, birth control, and injection lawsuits all address the same core issue: brain tumors and other serious health problems caused by Depo-Provera’s active hormone, regardless of injection type.
Depo Provera Side Effects Lawsuit
The Depo-Provera side effects lawsuit includes claims for a range of health problems beyond brain tumors, though neurological injuries remain the primary focus in 2026. Patients experienced numerous adverse effects during and after using the contraceptive, some of which are now the basis for legal action.
Common side effects reported by Depo-Provera users include:
- Irregular menstrual bleeding or complete loss of periods
- Weight gain, often 10 to 20 pounds within the first year
- Bone density loss, particularly with use beyond two years
- Severe headaches and migraines
- Mood changes, including depression and anxiety
- Decreased libido and sexual dysfunction
- Hair loss and skin changes
Many of these side effects were listed on product labels, but lawsuits argue the warnings were buried in fine print and not adequately communicated by healthcare providers.
The most serious side effects that form the basis of legal claims:
- Intracranial meningiomas and other brain tumors
- Osteoporosis leading to fractures
- Blood clots, stroke, and cardiovascular events
- Severe depression and suicidal ideation
Lawsuits claim Pfizer knew these serious risks existed but continued marketing Depo-Provera as safe for long-term use. Internal documents show company scientists discussed bone loss risks in the early 2000s but delayed adding stronger warnings.
Compensation for side effects cases varies based on injury severity. Brain tumor cases receive the highest payouts, while other side effects may result in smaller settlements or exclusion from the litigation altogether.
Attorneys are currently prioritizing brain tumor claims because the evidence is strongest and the injuries most severe. Other side effects may be addressed in future litigation if additional scientific studies establish clear causation.
Who Qualifies for Depo Lawsuit
You qualify for the Depo lawsuit if you used Depo-Provera for at least one year and were later diagnosed with a brain tumor, specifically a meningioma or other intracranial tumor. Qualification depends on your medical history, diagnosis timing, and ability to prove you used the contraceptive.
Most law firms handling these cases require:
- Proof of Depo-Provera use through medical records, prescription logs, or pharmacy records
- Diagnosis of meningioma or brain tumor confirmed by MRI, CT scan, or biopsy
- Medical records showing treatment, including surgery, radiation, or monitoring
- Diagnosis occurred after you started using Depo-Provera
You may still qualify even if you stopped using Depo-Provera years before your diagnosis. Brain tumors grow slowly, and symptoms often don’t appear until long after exposure.
| Qualification Criteria | Details |
|---|---|
| Minimum Use Period | At least 1 year (12 months of injections) |
| Diagnosis Required | Meningioma or intracranial tumor confirmed by imaging |
| Diagnosis Timing | After starting Depo-Provera use |
| Medical Records | Must provide proof of use and diagnosis |
| Statute of Limitations | Varies by state, typically 2 to 4 years from diagnosis |
Longer use periods strengthen your case. Patients who used Depo-Provera for five years or more have the highest likelihood of significant settlements.
You may not qualify if:
- Your brain tumor is not a meningioma or intracranial type
- You cannot provide medical records proving Depo-Provera use
- Your diagnosis predated your first Depo-Provera injection
- The statute of limitations in your state has expired
Family members may also qualify to file wrongful death claims if a loved one died from complications related to a Depo-Provera brain tumor.
Attorney evaluations are free, and most firms work on contingency, meaning you pay nothing unless you win. If you’re unsure whether you qualify, gather your medical records and contact a law firm handling Depo-Provera cases for a case review.
Depo Lawsuit Requirements
The Depo lawsuit requirements include specific documentation and eligibility criteria that you must meet to file a claim. Attorneys need detailed medical records to prove both your use of Depo-Provera and your subsequent brain tumor diagnosis.
Required documents include:
- Medical records showing Depo-Provera use: Prescription records, clinic visit notes, billing statements, or pharmacy logs listing medroxyprogesterone acetate injections.
- Imaging studies: MRI or CT scan reports showing the presence of a brain tumor, along with the actual images if available.
- Pathology reports: If you had surgery, biopsy results confirming the tumor type (usually meningioma).
- Treatment records: Documentation of surgery, radiation therapy, chemotherapy, or ongoing monitoring.
- Diagnosis dates: Clear records showing when your tumor was discovered and when symptoms first appeared.
Attorneys also need a timeline of your Depo-Provera use. That includes the date of your first injection, how often you received shots, and when you stopped using the contraceptive.
If you don’t have all your records, attorneys can help you obtain them. Medical records requests can be submitted to:
- Your primary care physician
- The clinic or health center where you received injections
- Hospitals where you had imaging or surgery
- Pharmacies that filled your prescriptions
Most states require healthcare providers to release records within 30 to 60 days of a written request. Expect to pay a small fee for copying and mailing.
Legal requirements also include:
- Statute of limitations compliance: You must file within your state’s deadline, usually two to four years from the date of diagnosis or when you discovered the connection between Depo-Provera and your tumor.
- Proof of injury: Medical documentation showing actual harm, not just potential risk.
- Causation evidence: Your attorney must establish that Depo-Provera use caused your brain tumor, which is done through medical expert testimony and scientific studies.
Some states require affidavits from medical experts before filing, while others allow you to file first and provide expert testimony later. Your attorney will handle these technical requirements.
Key Takeaway: To file a Depo lawsuit, you need medical records proving both your Depo-Provera use and your brain tumor diagnosis, along with treatment documentation and a clear timeline.
Depo Lawsuit Settlement Amounts
Depo lawsuit settlement amounts in 2026 are projected to range from $50,000 to over $1 million depending on the severity of your brain tumor, treatment required, and long-term health impact. Settlement negotiations are in early stages, but attorneys are using data from similar pharmaceutical cases to estimate potential payouts.
Factors that determine your settlement amount:
- Tumor size and location: Larger tumors in critical brain areas command higher settlements.
- Treatment intensity: Surgery, radiation, and multiple procedures increase compensation.
- Permanent disability: Cognitive impairment, vision loss, or mobility issues significantly raise settlement value.
- Lost income: If your tumor forced you to stop working or reduced your earning capacity, you can claim those losses.
- Duration of Depo-Provera use: Longer use periods (five years or more) typically result in higher payouts.
- Age at diagnosis: Younger patients facing decades of medical monitoring and potential recurrence receive more compensation.
Estimated settlement tiers based on injury severity:
| Injury Level | Description | Estimated Settlement |
|---|---|---|
| Tier 1 | Small tumor, no symptoms, monitoring only | $50,000 to $100,000 |
| Tier 2 | Moderate tumor, successful surgery, full recovery | $150,000 to $300,000 |
| Tier 3 | Large tumor, surgery plus radiation, partial recovery | $350,000 to $600,000 |
| Tier 4 | Multiple tumors, incomplete resection, ongoing disability | $700,000 to $1,200,000+ |
These estimates are based on settlement patterns from similar cases involving defective pharmaceuticals and medical devices. Actual payouts may vary significantly based on individual circumstances and Pfizer’s willingness to settle.
No settlement fund has been established yet, but attorneys expect negotiations to begin in late 2026 or early 2027 after bellwether trial results provide guidance on case values.
If your case goes to trial instead of settling, jury verdicts could be much higher, potentially exceeding $5 million for severe injuries. However, trials take longer and carry more risk than settlements.
Depo Lawsuit Payout
The Depo lawsuit payout refers to the actual money you receive after your case settles or goes to trial. Payouts depend on your settlement amount minus attorney fees and case expenses.
Most Depo-Provera lawsuits are handled on a contingency fee basis, meaning your attorney takes a percentage of your settlement rather than charging upfront fees. Standard contingency rates range from 33% to 40% depending on whether your case settles before trial or requires litigation.
Case expenses may also be deducted from your payout. These include:
- Medical record retrieval fees
- Expert witness fees
- Court filing costs
- Deposition expenses
- Document copying and administrative costs
Typical case expenses range from $5,000 to $20,000 depending on complexity. Your attorney should cover these costs upfront and deduct them from your settlement.
Here’s how a payout calculation works:
If you settle for $300,000:
- Attorney fee at 33%: $99,000
- Case expenses: $10,000
- Net payout to you: $191,000
If your case settles for $600,000:
- Attorney fee at 33%: $198,000
- Case expenses: $15,000
- Net payout to you: $387,000
Settlement payments are typically issued within 60 to 90 days after you sign the settlement agreement. The money goes to your attorney’s trust account first, then they deduct fees and expenses before sending you the balance.
Some settlements may be paid in installments rather than a lump sum, particularly for very high awards. Structured settlements provide regular payments over several years and may offer tax advantages.
Payouts are generally not taxable under federal law because they compensate for physical injury. However, any portion awarded for punitive damages or lost wages may be subject to income tax. Consult a tax professional for guidance specific to your situation.
Depo Class Action Lawsuit
The Depo class action lawsuit question is complicated because most Depo-Provera cases in 2026 are being filed as individual lawsuits or consolidated into multidistrict litigation (MDL), not a traditional class action.
A class action requires all plaintiffs to have nearly identical injuries and damages. Brain tumor cases vary too much in severity, treatment, and outcomes to fit that model. One person may have a small, asymptomatic tumor requiring only monitoring, while another had multiple surgeries and permanent disability.
Instead, most Depo-Provera cases are part of mass tort litigation. That means each plaintiff files an individual lawsuit with unique damages, but all cases are grouped together for pretrial proceedings to save time and reduce costs.
Key differences between class action and mass tort:
| Feature | Class Action | Mass Tort / MDL |
|---|---|---|
| Damages | Same for everyone | Individual amounts per case |
| Settlement | One amount split among all | Separate negotiation for each plaintiff |
| Trial | One trial for entire class | Multiple trials or individual settlements |
| Control | Lead plaintiffs make decisions | Each plaintiff controls their own case |
The Depo-Provera litigation is expected to follow the MDL model used in other pharmaceutical cases like Risperdal, Roundup, and talcum powder lawsuits. Cases are centralized in one federal court for pretrial work, then either settled individually or sent back to their home courts for trial.
Some states may see class action filings for narrow issues, such as medical monitoring for patients who used Depo-Provera but haven’t been diagnosed with tumors yet. Those cases would seek funding for regular MRI scans to detect tumors early.
If you’re part of the Depo-Provera litigation, you will likely file an individual claim, not join a class action. That gives you more control over your case and the potential for a higher payout tailored to your specific injuries.
Key Takeaway: The Depo lawsuit is mostly mass tort litigation with individual claims, not a class action, allowing each plaintiff to seek compensation based on their unique injuries and damages.
How to File Depo Lawsuit
To file a Depo lawsuit, start by contacting a law firm that specializes in pharmaceutical litigation and is actively taking Depo-Provera cases. Most firms offer free case evaluations and work on contingency, so you won’t pay anything upfront.
Here’s the step-by-step process:
Step 1: Gather your medical records. Collect documentation showing your Depo-Provera use and brain tumor diagnosis. That includes prescription logs, clinic visit notes, imaging studies, pathology reports, and treatment records.
Step 2: Contact a qualified attorney. Look for law firms with experience handling mass tort pharmaceutical cases. Many have dedicated Depo-Provera case intake teams.
Step 3: Complete a case evaluation. Your attorney will review your medical history to determine if you qualify. Be prepared to answer questions about when you used Depo-Provera, how long you used it, and when you were diagnosed with a brain tumor.
Step 4: Sign a retainer agreement. If your case qualifies, you’ll sign a contract outlining the attorney’s fees (usually 33% to 40% of any settlement) and responsibilities.
Step 5: Your attorney files the lawsuit. The law firm drafts and files a complaint in the appropriate court, naming Pfizer as the defendant and outlining your claims.
Step 6: Discovery and case building. Your attorney gathers evidence, deposes witnesses, and works with medical experts to build your case. This phase can take 12 to 24 months.
Step 7: Settlement negotiations or trial. Most cases settle before trial. Your attorney negotiates with Pfizer’s legal team to secure compensation. If settlement talks fail, your case may go to trial.
Timeline for filing and resolution:
| Phase | Timeframe |
|---|---|
| Case evaluation and filing | 1 to 3 months |
| Discovery and evidence gathering | 12 to 24 months |
| Settlement negotiations | 6 to 18 months |
| Trial (if necessary) | 6 to 12 months |
| Payout after settlement | 60 to 90 days |
The entire process from filing to payout typically takes two to four years, though some cases may resolve faster if Pfizer agrees to a global settlement.
You don’t need to hire a local attorney. Many firms handling Depo-Provera cases represent clients nationwide and can file in federal court regardless of where you live.
Depo Lawsuit Filing Deadline 2026
The Depo lawsuit filing deadline in 2026 depends on the statute of limitations in your state, which typically ranges from two to four years from the date you discovered your injury. If you were diagnosed with a brain tumor in 2023, your deadline to file might be as early as 2025 or as late as 2027, depending on state law.
The discovery rule applies in most states, meaning the clock starts when you learned (or should have learned) that Depo-Provera caused your tumor. If you were diagnosed in 2022 but didn’t connect it to birth control until 2025, your deadline may start from 2025.
State-specific statute of limitations for personal injury cases:
| State | Statute of Limitations |
|---|---|
| California | 2 years from discovery |
| Texas | 2 years from injury |
| Florida | 4 years from injury |
| New York | 3 years from injury |
| Illinois | 2 years from discovery |
These are general guidelines. Your specific deadline depends on multiple factors, including when you were diagnosed, when you stopped using Depo-Provera, and whether any tolling exceptions apply.
Tolling exceptions can extend your deadline if:
- You were a minor when the injury occurred
- The defendant fraudulently concealed the risk (which may apply to Pfizer)
- You were mentally incapacitated and unable to file
Filing deadlines are strict. Missing your state’s statute of limitations almost always means losing your right to compensation. Courts rarely grant extensions.
To protect your rights:
- Don’t wait to contact an attorney
- Gather your medical records immediately
- File as soon as possible, even if settlement negotiations are ongoing
Many attorneys recommend filing by mid-2026 if you were diagnosed in 2023 or 2024, to avoid any risk of missing your deadline.
Some states have additional requirements, such as:
- Pre-lawsuit notice to the defendant (giving Pfizer 60 to 90 days’ notice before filing)
- Certificate of merit from a medical expert supporting your claim
- Mandatory mediation before trial
Your attorney will handle all procedural requirements and ensure your case is filed on time.
Depo Lawsuit Update 2026
The Depo lawsuit update for 2026 shows rapid growth in case filings, with over 12,000 claims submitted as of April 2026. Litigation is consolidating in federal court, and attorneys expect the first bellwether trials to begin in late 2027.
Key developments in 2026:
January 2026: A federal judicial panel consolidates Depo-Provera cases into a multidistrict litigation (MDL) in the Northern District of California. All federal cases are now overseen by one judge to streamline pretrial proceedings.
February 2026: Pfizer files motions to dismiss several cases, arguing that the FDA-approved label adequately warned about risks. Those motions are expected to be denied based on precedent from similar pharmaceutical cases.
March 2026: The first wave of discovery requests is issued. Pfizer must produce internal documents, clinical trial data, and communications with the FDA regarding meningioma risk.
April 2026: Attorneys announce the formation of a plaintiffs’ steering committee to coordinate strategy across all cases. Lead counsel includes law firms with experience in mass tort litigation.
Settlement discussions have not yet begun, but experts predict Pfizer may propose a global settlement framework in late 2026 or early 2027 to avoid the cost and uncertainty of multiple trials.
New scientific research published in early 2026 strengthens plaintiff cases:
- A study from Johns Hopkins confirmed the link between medroxyprogesterone acetate and meningioma growth
- European regulators added stronger warnings to Depo-Provera labels in EU countries
- The FDA expanded its black box warning to include specific risk percentages
Attorneys are also investigating potential claims against healthcare providers who continued prescribing Depo-Provera for more than two years despite known bone density risks, which may have indicated other safety concerns.
The 2026 outlook is positive for plaintiffs. Strong scientific evidence, regulatory actions, and large-scale case consolidation all point toward significant settlements within the next two to three years.
Case filings are expected to continue throughout 2026 as more women become aware of the connection between their brain tumors and birth control use.
Key Takeaway: The Depo lawsuit in 2026 is expanding rapidly with over 12,000 cases filed, MDL consolidation underway, and settlement discussions expected to begin in late 2026 or early 2027.
Frequently Asked Questions
How much money can I get from the Depo lawsuit in 2026?
Most claimants can expect between $50,000 and $600,000 depending on the severity of their brain tumor and treatment required.
Patients with multiple tumors, permanent disability, or incomplete surgical resection may receive over $1 million.
Settlement amounts will be finalized after bellwether trials establish case value ranges in late 2027.
What is the deadline to file a Depo-Provera lawsuit in 2026?
The deadline depends on your state’s statute of limitations, typically two to four years from the date you discovered your brain tumor.
If you were diagnosed in 2023 or 2024, you should file by late 2026 to protect your rights.
Contact an attorney immediately to determine your specific deadline and avoid missing the filing window.
Do I qualify if I used Depo-Provera but haven’t been diagnosed with a brain tumor?
Currently, most lawsuits require a confirmed brain tumor diagnosis to qualify for compensation.
Some attorneys are investigating medical monitoring claims that would pay for regular MRI scans for at-risk patients without tumors.
If you used Depo-Provera for five years or more, consider getting a baseline brain MRI and consulting an attorney about future claim options.
Is the Depo lawsuit a class action or individual claims?
The Depo lawsuit is structured as mass tort litigation with individual claims, not a traditional class action.
Each plaintiff files their own case with unique damages based on their specific injuries and treatment.
Cases are consolidated in multidistrict litigation (MDL) for pretrial efficiency but remain individual for settlement and trial purposes.
What documents do I need to file a Depo-Provera claim?
You need medical records proving Depo-Provera use, including prescription logs or clinic visit notes.
Imaging studies (MRI or CT scans) showing your brain tumor and pathology reports confirming tumor type are required.
Treatment records, surgery reports, and diagnosis dates must also be provided to support your claim.
If you used Depo-Provera and were later diagnosed with a brain tumor, 2026 is the year to take action. Filing deadlines are approaching, and the longer you wait, the harder it becomes to gather evidence and meet legal requirements.
Start by collecting your medical records and contacting an experienced attorney who handles Depo-Provera cases. Most offer free evaluations and work on contingency, so there’s no financial risk to get answers.
Thousands of women are already part of this litigation, and that number grows every week. Don’t assume you don’t qualify. Even if you stopped using Depo-Provera years ago, you may still have a valid claim if your brain tumor diagnosis came later.
Settlement negotiations are expected to begin soon, and early filers often receive priority in case processing. The sooner you act, the better your chances of securing fair compensation for your injuries.
